Escitalopram Clinical Trials
13 recruitingDrug
Phase 45Phase 23Phase 32Not Applicable2
Showing 1–13 of 13 trials
Recruiting
Phase 2
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
Mild Neurocognitive DisorderMajor Depressive DisorderHIV
National Institute of Allergy and Infectious Diseases (NIAID)186 enrolled40 locationsNCT06705478
Recruiting
Phase 4
TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children
Depression - Major Depressive DisorderDepressive Episodes
Poznan University of Medical Sciences180 enrolled1 locationNCT07478796
Recruiting
Phase 4
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
Major Depressive Disorder
Nova Scotia Health Authority400 enrolled7 locationsNCT05017311
Recruiting
Phase 2
Escitalopram in Asthma Patients With Frequent Exacerbation
Asthma
University of Texas Southwestern Medical Center105 enrolled1 locationNCT06216535
Recruiting
Not Applicable
Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole
Major Depressive Disorder (MDD)Rumination
Central South University108 enrolled1 locationNCT06937476
Recruiting
Phase 3
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Major Depressive DisorderBipolar DepressionSchizophrenia and Related Disorders
Dr. Inge Winter1,254 enrolled1 locationNCT05603104
Recruiting
Phase 3
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Bipolar Depression
Dr. Inge Winter418 enrolled13 locationsNCT05973786
Recruiting
Phase 2
Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD
MDD
Vigonvita Life Sciences400 enrolled1 locationNCT06828887
Recruiting
Phase 4
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
DepressionAnxious Depression
University of Cincinnati84 enrolled1 locationNCT04245748
Recruiting
Phase 4
Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)
Anxiety
University of Cincinnati132 enrolled1 locationNCT04623099
Recruiting
Phase 4
Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)
AnxietyDepressive Symptoms
University of Cincinnati60 enrolled1 locationNCT04245436
Recruiting
Not Applicable
Development and Application of Comprehensive Intervention Techniques for Adolescent Depression
Depressive DisorderAdolescent
First Affiliated Hospital of Zhejiang University100 enrolled1 locationNCT05945342
Recruiting
Bariatric Surgery and Pharmacokinetics of Escitalopram
Obesity, Morbid
Norwegian University of Science and Technology12 enrolled1 locationNCT03460379